All lobbying filings
ULTRAGENYX PHARMACEUTICAL INC.
ULTRAGENYX PHARMACEUTICAL INC. filed a Q2 report for ULTRAGENYX PHARMACEUTICAL INC. on July 21, 2025, reporting no lobbying activity.
Lobbying for ULTRAGENYX PHARMACEUTICAL INC. · Pharmaceuticals
Filing · LD-2 quarterly report
Q2 reportNo activity
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Expenses
$140,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
California
Lobbying activity
0
No itemized activity in this filing.